Results 131 to 140 of about 7,581 (239)

Antimicrobial susceptibility and resistance mechanisms to antipseudomonal β-lactams in Pseudomonas aeruginosa isolates from blood

Microbiology Spectrum
Bloodstream infection caused by Pseudomonas aeruginosa with antimicrobial resistance can be difficult to treat. Herein, we investigated antimicrobial susceptibility to major antipseudomonal β-lactams and analyzed the relationship between resistance ...
Mika Murata, Kosuke Kosai, Fujiko Mitsumoto-Kaseida, Norihito Kaku, Hiroo Hasegawa, Koichi Izumikawa, Hiroshi Mukae, Katsunori Yanagihara   +7 more
doaj   +1 more source

1594. Ceftolozane–Tazobactam Demonstrates Higher In Vitro Susceptibility than Ceftazidime–Avibactam Against Pseudomonas aeruginosa Isolated from Respiratory Tract of Adult Cystic Fibrosis Patients [PDF]

, 2019
Patrick J. Nolan, Tiffeny T. Smith, James D. Finklea, Leah Cohen, Raksha Jain   +4 more
openalex   +1 more source

PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease [PDF]

, 2016
Alan J. Xiao, Jennifer A. Huntington, Luzelena Caro, Myra W. Popejoy, Ravina Kullar   +4 more
core   +1 more source

Ceftazidime-avibactam versus ceftolozane-tazobactam in the treatment of drug-resistant Pseudomonas aeruginosa: a meta-analysis [PDF]

Thamer A. Almangour, Sulaiman Alzunaydi, Felwah AlManea, Aisha Alshahwan, Shahd Mohammad, Leen Ghonem, Essam A. Tawfik, Mohammed Alessa, Yazed Saleh Alsowaida   +8 more
openalex   +1 more source

Activity of Ceftolozane-Tazobactam and Comparators When Tested against Bacterial Surveillance Isolates Collected from Pediatric Patients in the US during 2012–2016 as Part of a Global Surveillance Program [PDF]

, 2017
Dee Shortridge, Leonard R Duncan, Michael A. Pfaller, Robert K. Flamm   +3 more
openalex   +1 more source

A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam [PDF]

, 2023
Lucinda J. Van Anglen, Claudia P. Schroeder, Kimberly A Couch   +2 more
openalex   +1 more source

Development of an HPLC–MS/MS Method for the Determination of Ceftolozane/Tazobactam in Bronchoalveolar Lavage Fluid [PDF]

, 2018
Christina Sutherland, Can C. Özbal, David P. Nicolau   +2 more
openalex   +1 more source

Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections [PDF]

, 2020
Sarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, Abdalhamid M Lagnf, Samuel Simon, Sahil Bhatia, Sarah Melvin, Molly E. Steed, Natalie A. Finch, Taylor Morrisette, Sandy Estrada, Joshua Rosenberg, Susan L. Davis, Michael J. Rybak   +13 more
openalex   +1 more source

Susceptibility profile and β-lactamase content of global Pseudomonas aeruginosa isolates resistant to ceftolozane/tazobactam and/or imipenem/relebactam—SMART 2016–21 [PDF]

, 2023
James A. Karlowsky, Sibylle Lob, Mark Estabrook, Fakhar Siddiqui, C Andrew DeRyke, Katherine Young, Mary Motyl, Daniel F. Sahm   +7 more
openalex   +1 more source

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI) [PDF]

, 2015
Joseph S. Solomkin, Ellie Hershberger, Benjamin Miller, Myra W. Popejoy, Ian R. Friedland, Judith N. Steenbergen, Minjung Yoon, Sylva H. Collins, Guojun Yuan, Philip S. Barie, Christian Eckmann   +10 more
openalex   +1 more source